A citation-based method for searching scientific literature

Bruno Dubois, Howard H Feldman, Claudia Jacova, Harald Hampel, José Luis Molinuevo, Kaj Blennow, Steven T DeKosky, Serge Gauthier, Dennis Selkoe, Randall Bateman, Stefano Cappa, Sebastian Crutch, Sebastiaan Engelborghs, Giovanni B Frisoni, Nick C Fox, Douglas Galasko, Marie-Odile Habert, Gregory A Jicha, Agneta Nordberg, Florence Pasquier, Gil Rabinovici, Philippe Robert, Christopher Rowe, Stephen Salloway, Marie Sarazin, Stéphane Epelbaum, Leonardo C de Souza, Bruno Vellas, Pieter J Visser, Lon Schneider, Yaakov Stern, Philip Scheltens, Jeffrey L Cummings. Lancet Neurol 2014
Times Cited: 1746







List of co-cited articles
538 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
41

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
37

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
28

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
15


CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Bob Olsson, Ronald Lautner, Ulf Andreasson, Annika Öhrfelt, Erik Portelius, Maria Bjerke, Mikko Hölttä, Christoffer Rosén, Caroline Olsson, Gabrielle Strobel,[...]. Lancet Neurol 2016
885
14

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.
Katya Rascovsky, John R Hodges, David Knopman, Mario F Mendez, Joel H Kramer, John Neuhaus, John C van Swieten, Harro Seelaar, Elise G P Dopper, Chiadi U Onyike,[...]. Brain 2011
13

Classification of primary progressive aphasia and its variants.
M L Gorno-Tempini, A E Hillis, S Weintraub, A Kertesz, M Mendez, S F Cappa, J M Ogar, J D Rohrer, S Black, B F Boeve,[...]. Neurology 2011
13



Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G Beach, Geidy E Serrano, Xiyun Chai, Nicholas K Proctor, Udo Eichenlaub, Henrik Zetterberg,[...]. Nat Med 2020
248
10

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.
Ian G McKeith, Bradley F Boeve, Dennis W Dickson, Glenda Halliday, John-Paul Taylor, Daniel Weintraub, Dag Aarsland, James Galvin, Johannes Attems, Clive G Ballard,[...]. Neurology 2017
10

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.
Bruno Dubois, Howard H Feldman, Claudia Jacova, Steven T Dekosky, Pascale Barberger-Gateau, Jeffrey Cummings, André Delacourte, Douglas Galasko, Serge Gauthier, Gregory Jicha,[...]. Lancet Neurol 2007
10

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.
Oskar Hansson, Sylvain Lehmann, Markus Otto, Henrik Zetterberg, Piotr Lewczuk. Alzheimers Res Ther 2019
124
9

Alzheimer's disease.
Philip Scheltens, Kaj Blennow, Monique M B Breteler, Bart de Strooper, Giovanni B Frisoni, Stephen Salloway, Wiesje Maria Van der Flier. Lancet 2016
8

High performance plasma amyloid-β biomarkers for Alzheimer's disease.
Akinori Nakamura, Naoki Kaneko, Victor L Villemagne, Takashi Kato, James Doecke, Vincent Doré, Chris Fowler, Qiao-Xin Li, Ralph Martins, Christopher Rowe,[...]. Nature 2018
630
7

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand,[...]. Lancet Neurol 2013
7


Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.
Bruno Dubois, Nicolas Villain, Giovanni B Frisoni, Gil D Rabinovici, Marwan Sabbagh, Stefano Cappa, Alexandre Bejanin, Stéphanie Bombois, Stéphane Epelbaum, Marc Teichmann,[...]. Lancet Neurol 2021
49
14

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
Gill Livingston, Jonathan Huntley, Andrew Sommerlad, David Ames, Clive Ballard, Sube Banerjee, Carol Brayne, Alistair Burns, Jiska Cohen-Mansfield, Claudia Cooper,[...]. Lancet 2020
7

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.
Oliver Preische, Stephanie A Schultz, Anja Apel, Jens Kuhle, Stephan A Kaeser, Christian Barro, Susanne Gräber, Elke Kuder-Buletta, Christian LaFougere, Christoph Laske,[...]. Nat Med 2019
316
6

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Niklas Mattsson, Nicholas C Cullen, Ulf Andreasson, Henrik Zetterberg, Kaj Blennow. JAMA Neurol 2019
210
6

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.
Elisabeth H Thijssen, Renaud La Joie, Amy Wolf, Amelia Strom, Ping Wang, Leonardo Iaccarino, Viktoriya Bourakova, Yann Cobigo, Hilary Heuer, Salvatore Spina,[...]. Nat Med 2020
204
6

High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.
Suzanne E Schindler, James G Bollinger, Vitaliy Ovod, Kwasi G Mawuenyega, Yan Li, Brian A Gordon, David M Holtzman, John C Morris, Tammie L S Benzinger, Chengjie Xiong,[...]. Neurology 2019
204
6

Criteria for the diagnosis of corticobasal degeneration.
Melissa J Armstrong, Irene Litvan, Anthony E Lang, Thomas H Bak, Kailash P Bhatia, Barbara Borroni, Adam L Boxer, Dennis W Dickson, Murray Grossman, Mark Hallett,[...]. Neurology 2013
838
6

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
Thomas G Beach, Sarah E Monsell, Leslie E Phillips, Walter Kukull. J Neuropathol Exp Neurol 2012
536
6

Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse.
Daniel Alcolea, Jordi Pegueroles, Laia Muñoz, Valle Camacho, Diego López-Mora, Alejandro Fernández-León, Nathalie Le Bastard, Els Huyck, Alicia Nadal, Verónica Olmedo,[...]. Ann Clin Transl Neurol 2019
42
14

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.
Antoine Leuzy, Konstantinos Chiotis, Steen G Hasselbalch, Juha O Rinne, Alexandre de Mendonça, Markus Otto, Alberto Lleó, Miguel Castelo-Branco, Isabel Santana, Jarkko Johansson,[...]. Brain 2016
88
6

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid.
Susan M Landau, Ming Lu, Abhinay D Joshi, Michael Pontecorvo, Mark A Mintun, John Q Trojanowski, Leslie M Shaw, William J Jagust. Ann Neurol 2013
234
6

Consensus classification of posterior cortical atrophy.
Sebastian J Crutch, Jonathan M Schott, Gil D Rabinovici, Melissa Murray, Julie S Snowden, Wiesje M van der Flier, Bradford C Dickerson, Rik Vandenberghe, Samrah Ahmed, Thomas H Bak,[...]. Alzheimers Dement 2017
220
6

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling,[...]. Nature 2016
6

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Howard H Feldman, Giovanni B Frisoni, Harald Hampel, William J Jagust, Keith A Johnson, David S Knopman,[...]. Neurology 2016
650
6

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
B Winblad, K Palmer, M Kivipelto, V Jelic, L Fratiglioni, L-O Wahlund, A Nordberg, L Bäckman, M Albert, O Almkvist,[...]. J Intern Med 2004
5

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Clifford R Jack, Marilyn S Albert, David S Knopman, Guy M McKhann, Reisa A Sperling, Maria C Carrillo, Bill Thies, Creighton H Phelps. Alzheimers Dement 2011
987
5

Research criteria for the diagnosis of prodromal dementia with Lewy bodies.
Ian G McKeith, Tanis J Ferman, Alan J Thomas, Frédéric Blanc, Bradley F Boeve, Hiroshige Fujishiro, Kejal Kantarci, Cristina Muscio, John T O'Brien, Ronald B Postuma,[...]. Neurology 2020
124
5

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
Clifford R Jack, David S Knopman, William J Jagust, Leslie M Shaw, Paul S Aisen, Michael W Weiner, Ronald C Petersen, John Q Trojanowski. Lancet Neurol 2010
5

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
Bradley T Hyman, Creighton H Phelps, Thomas G Beach, Eileen H Bigio, Nigel J Cairns, Maria C Carrillo, Dennis W Dickson, Charles Duyckaerts, Matthew P Frosch, Eliezer Masliah,[...]. Alzheimers Dement 2012
5

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Niklas Mattsson, Philip S Insel, Michael Donohue, Susan Landau, William J Jagust, Leslie M Shaw, John Q Trojanowski, Henrik Zetterberg, Kaj Blennow, Michael W Weiner. Brain 2015
161
5

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
Christopher M Clark, Michael J Pontecorvo, Thomas G Beach, Barry J Bedell, R Edward Coleman, P Murali Doraiswamy, Adam S Fleisher, Eric M Reiman, Marwan N Sabbagh, Carl H Sadowsky,[...]. Lancet Neurol 2012
501
5

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease.
Shorena Janelidze, Henrik Zetterberg, Niklas Mattsson, Sebastian Palmqvist, Hugo Vanderstichele, Olof Lindberg, Danielle van Westen, Erik Stomrud, Lennart Minthon, Kaj Blennow,[...]. Ann Clin Transl Neurol 2016
229
5


Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.
Flora H Duits, Pablo Martinez-Lage, Claire Paquet, Sebastiaan Engelborghs, Alberto Lleó, Lucrezia Hausner, José L Molinuevo, Erik Stomrud, Lucia Farotti, Inez H G B Ramakers,[...]. Alzheimers Dement 2016
124
5

Consensus guidelines for lumbar puncture in patients with neurological diseases.
Sebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, Kaj Blennow, Raf Brouns, Manuel Comabella, Irena Dujmovic, Wiesje van der Flier, Lutz Frölich, Daniela Galimberti,[...]. Alzheimers Dement (Amst) 2017
122
5

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Victor L Villemagne, Samantha Burnham, Pierrick Bourgeat, Belinda Brown, Kathryn A Ellis, Olivier Salvado, Cassandra Szoeke, S Lance Macaulay, Ralph Martins, Paul Maruff,[...]. Lancet Neurol 2013
5

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Thomas K Karikari, Tharick A Pascoal, Nicholas J Ashton, Shorena Janelidze, Andréa Lessa Benedet, Juan Lantero Rodriguez, Mira Chamoun, Melissa Savard, Min Su Kang, Joseph Therriault,[...]. Lancet Neurol 2020
236
5

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
Frank de Wolf, Mohsen Ghanbari, Silvan Licher, Kevin McRae-McKee, Luuk Gras, Gerrit Jan Weverling, Paulien Wermeling, Sanaz Sedaghat, M Kamran Ikram, Reem Waziry,[...]. Brain 2020
90
5

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Bruno Dubois, Harald Hampel, Howard H Feldman, Philip Scheltens, Paul Aisen, Sandrine Andrieu, Hovagim Bakardjian, Habib Benali, Lars Bertram, Kaj Blennow,[...]. Alzheimers Dement 2016
745
5

Current concepts in mild cognitive impairment.
R C Petersen, R Doody, A Kurz, R C Mohs, J C Morris, P V Rabins, K Ritchie, M Rossor, L Thal, B Winblad. Arch Neurol 2001
4

Mild cognitive impairment: clinical characterization and outcome.
R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen. Arch Neurol 1999
4

The Cellular Phase of Alzheimer's Disease.
Bart De Strooper, Eric Karran. Cell 2016
760
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.